159 related articles for article (PubMed ID: 16285906)
1. Near-infrared optical imaging of ovarian cancer xenografts with novel alpha 3-integrin binding peptide "OA02".
Aina OH; Marik J; Gandour-Edwards R; Lam KS
Mol Imaging; 2005; 4(4):439-47. PubMed ID: 16285906
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel targeting peptides for human ovarian cancer cells using "one-bead one-compound" combinatorial libraries.
Aina OH; Marik J; Liu R; Lau DH; Lam KS
Mol Cancer Ther; 2005 May; 4(5):806-13. PubMed ID: 15897245
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha 3 integrin.
Xiao W; Yao N; Peng L; Liu R; Lam KS
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):94-103. PubMed ID: 18712382
[TBL] [Abstract][Full Text] [Related]
4. Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.
Yao N; Xiao W; Wang X; Marik J; Park SH; Takada Y; Lam KS
J Med Chem; 2009 Jan; 52(1):126-33. PubMed ID: 19055415
[TBL] [Abstract][Full Text] [Related]
5. Canine malignant melanoma alpha-3 integrin binding peptides.
Aina OH; Maeda Y; Harrison M; Zwingenberger AL; Walker NJ; Lam KS; Kent MS
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):11-9. PubMed ID: 21722969
[TBL] [Abstract][Full Text] [Related]
6. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
[TBL] [Abstract][Full Text] [Related]
7. From combinatorial chemistry to cancer-targeting peptides.
Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
[TBL] [Abstract][Full Text] [Related]
8. The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle.
Xiao W; Wang Y; Lau EY; Luo J; Yao N; Shi C; Meza L; Tseng H; Maeda Y; Kumaresan P; Liu R; Lightstone FC; Takada Y; Lam KS
Mol Cancer Ther; 2010 Oct; 9(10):2714-23. PubMed ID: 20858725
[TBL] [Abstract][Full Text] [Related]
9. Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach.
Zhang H; Aina OH; Lam KS; de Vere White R; Evans C; Henderson P; Lara PN; Wang X; Bassuk JA; Pan CX
Urol Oncol; 2012 Sep; 30(5):635-45. PubMed ID: 20888272
[TBL] [Abstract][Full Text] [Related]
10. Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer.
Ke FY; Chen WY; Lin MC; Hwang YC; Kuo KT; Wu HC
Cancer Sci; 2020 Oct; 111(10):3478-3492. PubMed ID: 32648337
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
12. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.
Kimura RH; Cheng Z; Gambhir SS; Cochran JR
Cancer Res; 2009 Mar; 69(6):2435-42. PubMed ID: 19276378
[TBL] [Abstract][Full Text] [Related]
13. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR
Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753
[TBL] [Abstract][Full Text] [Related]
14. Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging.
Shaw SK; Liu W; Gómez Durán CFA; Schreiber CL; Betancourt Mendiola ML; Zhai C; Roland FM; Padanilam SJ; Smith BD
Chemistry; 2018 Sep; 24(52):13821-13829. PubMed ID: 30022552
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
